Heparanase as a molecular target of cancer chemotherapy

Siro Simizu, Keisuke Ishida, Hiroyuki Osada

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Cancer cells require the ability to degrade the extracellular matrix (ECM) in order to turn into invasive and metastatic cancer cells. Many proteases and glycosidases are essential in the process of dissolving the components of the ECM. An endo-β-D-glucuronidase, heparanase, is capable of specifically degrading one of the ECM components, heparan sulfate, and this activity is associated with the metastatic potential of tumor cells. Since heparanase mRNA is overexpressed in many human tumors (e.g., hepatomas, head and neck tumors, and esophageal carcinomas), the mechanisms regulating the activity of heparanase should be clarified; considering the possible role of heparanase in cancer, the development of heparanase inhibitors would appear to be advantageous. This review will focus on recent findings that have contributed to the characterization of heparanase and to the elucidation of the transcriptional regulation of heparanase mRNA expression, as well as the development of heparanase inhibitors.

Original languageEnglish
Pages (from-to)553-558
Number of pages6
JournalCancer Science
Volume95
Issue number7
DOIs
Publication statusPublished - 2004 Jul
Externally publishedYes

Fingerprint

Drug Therapy
Neoplasms
Extracellular Matrix
Messenger RNA
Heparitin Sulfate
heparanase
Glycoside Hydrolases
Glucuronidase
Hepatocellular Carcinoma
Peptide Hydrolases
Neck
Head
Carcinoma

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Heparanase as a molecular target of cancer chemotherapy. / Simizu, Siro; Ishida, Keisuke; Osada, Hiroyuki.

In: Cancer Science, Vol. 95, No. 7, 07.2004, p. 553-558.

Research output: Contribution to journalArticle

Simizu, Siro ; Ishida, Keisuke ; Osada, Hiroyuki. / Heparanase as a molecular target of cancer chemotherapy. In: Cancer Science. 2004 ; Vol. 95, No. 7. pp. 553-558.
@article{8fa9e53352db4a1fafcd9d096df28dac,
title = "Heparanase as a molecular target of cancer chemotherapy",
abstract = "Cancer cells require the ability to degrade the extracellular matrix (ECM) in order to turn into invasive and metastatic cancer cells. Many proteases and glycosidases are essential in the process of dissolving the components of the ECM. An endo-β-D-glucuronidase, heparanase, is capable of specifically degrading one of the ECM components, heparan sulfate, and this activity is associated with the metastatic potential of tumor cells. Since heparanase mRNA is overexpressed in many human tumors (e.g., hepatomas, head and neck tumors, and esophageal carcinomas), the mechanisms regulating the activity of heparanase should be clarified; considering the possible role of heparanase in cancer, the development of heparanase inhibitors would appear to be advantageous. This review will focus on recent findings that have contributed to the characterization of heparanase and to the elucidation of the transcriptional regulation of heparanase mRNA expression, as well as the development of heparanase inhibitors.",
author = "Siro Simizu and Keisuke Ishida and Hiroyuki Osada",
year = "2004",
month = "7",
doi = "10.1111/j.1349-7006.2004.tb02485.x",
language = "English",
volume = "95",
pages = "553--558",
journal = "Cancer Science",
issn = "1347-9032",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Heparanase as a molecular target of cancer chemotherapy

AU - Simizu, Siro

AU - Ishida, Keisuke

AU - Osada, Hiroyuki

PY - 2004/7

Y1 - 2004/7

N2 - Cancer cells require the ability to degrade the extracellular matrix (ECM) in order to turn into invasive and metastatic cancer cells. Many proteases and glycosidases are essential in the process of dissolving the components of the ECM. An endo-β-D-glucuronidase, heparanase, is capable of specifically degrading one of the ECM components, heparan sulfate, and this activity is associated with the metastatic potential of tumor cells. Since heparanase mRNA is overexpressed in many human tumors (e.g., hepatomas, head and neck tumors, and esophageal carcinomas), the mechanisms regulating the activity of heparanase should be clarified; considering the possible role of heparanase in cancer, the development of heparanase inhibitors would appear to be advantageous. This review will focus on recent findings that have contributed to the characterization of heparanase and to the elucidation of the transcriptional regulation of heparanase mRNA expression, as well as the development of heparanase inhibitors.

AB - Cancer cells require the ability to degrade the extracellular matrix (ECM) in order to turn into invasive and metastatic cancer cells. Many proteases and glycosidases are essential in the process of dissolving the components of the ECM. An endo-β-D-glucuronidase, heparanase, is capable of specifically degrading one of the ECM components, heparan sulfate, and this activity is associated with the metastatic potential of tumor cells. Since heparanase mRNA is overexpressed in many human tumors (e.g., hepatomas, head and neck tumors, and esophageal carcinomas), the mechanisms regulating the activity of heparanase should be clarified; considering the possible role of heparanase in cancer, the development of heparanase inhibitors would appear to be advantageous. This review will focus on recent findings that have contributed to the characterization of heparanase and to the elucidation of the transcriptional regulation of heparanase mRNA expression, as well as the development of heparanase inhibitors.

UR - http://www.scopus.com/inward/record.url?scp=4143083982&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4143083982&partnerID=8YFLogxK

U2 - 10.1111/j.1349-7006.2004.tb02485.x

DO - 10.1111/j.1349-7006.2004.tb02485.x

M3 - Article

C2 - 15245589

AN - SCOPUS:4143083982

VL - 95

SP - 553

EP - 558

JO - Cancer Science

JF - Cancer Science

SN - 1347-9032

IS - 7

ER -